💙 🔷 Not impressed by Big Tech in Q3? Explore these Blue Chip Bargains insteadExplore for free

Valeant to host investor day on Dec. 16, discuss forecast, business

Published 2015-11-20, 08:43 a/m
© Reuters.  Valeant to host investor day on Dec. 16, discuss forecast, business
BHC
-

Nov 20 (Reuters) - Valeant Pharmaceuticals International Inc (N:VRX)
VRX.TO VRX.N said on Friday that it would host its investor
day on Dec. 16 to discuss its financial guidance and business
operations.
The Canadian drugmaker has tried to assuage investor
concerns after influential short-seller Citron Research in late
October alleged that the company had inflated its revenue by
using specialty pharmacies. urn:newsml:reuters.com:*:nCNW151K8a
Since then, Valeant has severed ties with specialty
pharmacy, Philidor Rx Services, and said its dermatology
business would be hurt in the short term. urn:newsml:reuters.com:*:nL1N135104
Up to Thursday's close, Valeant's U.S.-listed stock had
nearly halved since Citron's report on Oct. 20. urn:newsml:reuters.com:*:nL1N12L1OH

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.